Owens & Minor (NYSE:OMI) in our automated value investing analysis, with the cash flow history and price comparison below.
Advertisement helps keep Trendshare free for most readers.
Estimate how long you need to hold Owens & Minor to reach your target.
Hmm, we can't give any reliable projection for Owens & Minor's growth rate. The company either has too few years of historical data for us to examine, or it's in the habit of losing money.
None of this means it's a bad stock. Maybe it's new and growing quickly, or maybe it's turning things around. We can't say anything sensible about it, so we won't say it's obviously undervalued right now. Proceed at your own risk!
| Advantages | Disadvantages | Neutral |
|---|---|---|
|
|
|
| OMI Price (Owens & Minor stock price per share) |
$0.00 | |
| PE Ratio versus Sector | 108% higher than other Healthcare stocks | |
| PE Ratio versus Industry | 39% lower than other Medical Distribution stocks | |
| Cash Yield | -5.08% | |
| Free Cash Flow Jitter | 142% |
No open-market insider buys or sells are recorded for the last 12 months.
Open-market buys and sells reported by Owens & Minor's officers, directors, and 10% owners on SEC Form 4. Routine transactions (tax withholding, option exercises, and stock grants) are excluded -- these are discretionary trades only.
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2025-08-14 | Coliseum Capital Management, LLC | Buy | 492,852 | $5.31 |
| 2025-08-13 | Coliseum Capital Management, LLC | Buy | 325,000 | $5.46 |
| 2025-08-12 | Coliseum Capital Management, LLC | Buy | 720,000 | $5.15 |
| 2025-04-10 | Coliseum Capital Management, LLC | Buy | 80,000 | $7.19 |
| 2025-04-09 | Coliseum Capital Management, LLC | Buy | 225,000 | $7.39 |
| 2025-04-08 | Coliseum Capital Management, LLC | Buy | 105,000 | $7.96 |
| 2025-04-07 | Coliseum Capital Management, LLC | Buy | 240,000 | $7.84 |
| 2025-04-04 | Coliseum Capital Management, LLC | Buy | 128,356 | $8.14 |
| 2025-04-03 | Coliseum Capital Management, LLC | Buy | 160,000 | $8.53 |
| 2025-03-04 | Coliseum Capital Management, LLC | Buy | 800,000 | $9.75 |
Related guides: good annual rate of return · high-yield stocks · forecasting earnings growth
We do not estimate a fair value for Owens & Minor while its free cash flow growth is not positive, so there is no value comparison here.
Positive free cash flow appears in 16 of the 18 fiscal years we hold for Owens & Minor from its current SEC filer.
Free cash flow from the first three years of data averaged $120.5 million, and from the last three $135.2 million: a rise.
Year-to-year variability in free cash flow is volatile, measured at 142%.
These numbers change when new filings or prices arrive, so treat this page as a snapshot and check the company's own filings.
Dividends are not in our data for Owens & Minor.
Its trailing P/E ratio is 108% above the average for stocks in the Healthcare sector.
Its trailing P/E ratio is 39% below the average for stocks in the Medical Distribution industry.
A P/E ratio depends on trailing earnings, which one-time items can distort, so a lower P/E is not by itself evidence of value.
Every fiscal year on this page is reported by one SEC filer, CIK 75252.
Each figure on this page comes from that filer.
Advertisement supports free stock analysis content.
Does Owens & Minor have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.
This example shows how we apply the Trendshare checklist to OMI: earnings power, cash generation, valuation, and margin of safety.
We check: business quality, free cash flow, P/E, and margin of safety.
Most Popular Articles
Precious Metals for Value Investors
Why Do Companies Perform Stock Buybacks?
How to Make Money with Penny Stocks
How to Invest $1000 in the Stock Market
Facebook Stock Price and Value